Exited position

Seth Klarman’s Cardinal Health Inc (CAH) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Baupost GroupVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2016Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares5.10MHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

Baupost Group first reported Cardinal Health Inc in Q4 2016. The reported position was increased across later filings. The latest verified relationship event shows that Baupost Group sold the entire position in Q1 2019, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2019
Sold the entire position−5.10M shares · No shares reported at quarter-end
Q4 2017
Bought 101.6% more+2.57M shares · 5.10M shares reported after the change
Filing context

Quarter-end price $61.27 · Estimated holding basis $68.45

Q3 2017
Bought 24.6% more+500.00K shares · 2.53M shares reported after the change
Filing context

Quarter-end price $66.92 · Estimated holding basis $75.75

Q4 2016
New position+1.03M shares · 1.03M shares reported
Filing context

Quarter-end price $71.97 · Estimated holding basis $71.97

2 unchanged quarters are collapsed by default.

Portfolio importance

How important was Cardinal Health Inc in Baupost Group’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.6%Q4 2018
Last reported rank#28of 37 reported positions
Peak portfolio weight3.1%Q4 2017
Best historical rank#11Q1 2018
At peak importanceQ4 2017
CAH
3.1%
Largest holding
11.2%
Cross-investor discovery

Who else owns Cardinal Health Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Joel GreenblattGotham Asset Management
CAH0.1% of reported portfolio
Ray DalioBridgewater Associates, LP
CAH0.1% of reported portfolio
Explore Cardinal Health Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$234.892026-09-14

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

This tracker follows Baupost Group LLC/MA’s Form 13F disclosures—not Seth Klarman’s personal brokerage account. Form 13F reports quarter-end U.S.-listed positions and certain options, but it does not reveal exact trade dates, execution prices, short positions or the purpose of an option position.